Dantong Sun

1.6k total citations
43 papers, 1.2k citations indexed

About

Dantong Sun is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dantong Sun has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 19 papers in Molecular Biology and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dantong Sun's work include Lung Cancer Treatments and Mutations (17 papers), Chromatin Remodeling and Cancer (11 papers) and Cancer Mechanisms and Therapy (9 papers). Dantong Sun is often cited by papers focused on Lung Cancer Treatments and Mutations (17 papers), Chromatin Remodeling and Cancer (11 papers) and Cancer Mechanisms and Therapy (9 papers). Dantong Sun collaborates with scholars based in China, United States and United Kingdom. Dantong Sun's co-authors include Helei Hou, Xiaochun Zhang, Huan Wang, William H. Klein, Kan Ding, Steven W. Wang, Lin Gan, Randy L. Johnson, Helei Hou and Dihua Yu and has published in prestigious journals such as Journal of Clinical Oncology, Genes & Development and SHILAP Revista de lepidopterología.

In The Last Decade

Dantong Sun

41 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dantong Sun China 18 739 459 259 151 141 43 1.2k
Marco Gymnopoulos United States 13 835 1.1× 262 0.6× 193 0.7× 158 1.0× 143 1.0× 16 1.2k
Denis Tvorogov Finland 20 847 1.1× 682 1.5× 94 0.4× 112 0.7× 155 1.1× 29 1.4k
Ross Lake United States 15 741 1.0× 269 0.6× 229 0.9× 120 0.8× 196 1.4× 22 1.1k
Verline Justilien United States 21 1.3k 1.8× 475 1.0× 161 0.6× 72 0.5× 328 2.3× 31 1.7k
Ren Xu United States 17 483 0.7× 222 0.5× 111 0.4× 193 1.3× 129 0.9× 38 1.0k
Joseph L.‐K. Chan United States 18 1.0k 1.4× 555 1.2× 139 0.5× 112 0.7× 241 1.7× 23 1.4k
Bárbara Meléndez Spain 22 859 1.2× 439 1.0× 241 0.9× 59 0.4× 421 3.0× 66 1.6k
Laura Gualandi Sweden 9 966 1.3× 326 0.7× 91 0.4× 157 1.0× 245 1.7× 14 1.3k
Satoru Osuka Japan 21 677 0.9× 355 0.8× 158 0.6× 93 0.6× 314 2.2× 42 1.3k
Caroline A. Nebhan United States 12 667 0.9× 1.0k 2.2× 659 2.5× 154 1.0× 208 1.5× 23 1.7k

Countries citing papers authored by Dantong Sun

Since Specialization
Citations

This map shows the geographic impact of Dantong Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dantong Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dantong Sun more than expected).

Fields of papers citing papers by Dantong Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dantong Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dantong Sun. The network helps show where Dantong Sun may publish in the future.

Co-authorship network of co-authors of Dantong Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Dantong Sun. A scholar is included among the top collaborators of Dantong Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dantong Sun. Dantong Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xia, Qingqing, Dantong Sun, Chengcheng Liu, et al.. (2025). Lactylation: the metabolic–immune hub in autoimmune diseases. Frontiers in Immunology. 16. 1651923–1651923.
2.
Sun, Dantong, Zhen Yang, Yongzhi Lu, et al.. (2024). SMARCA4 mutations and expression in lung adenocarcinoma: prognostic significance and impact on the immunotherapy response. FEBS Open Bio. 14(12). 2086–2103. 5 indexed citations
3.
Sun, Dantong, Haili Qian, Junling Li, & Puyuan Xing. (2024). Targeting MDM2 in malignancies is a promising strategy for overcoming resistance to anticancer immunotherapy. Journal of Biomedical Science. 31(1). 17–17. 11 indexed citations
4.
Zhou, Hai, et al.. (2023). Role of YES1 signaling in tumor therapy resistance. SHILAP Revista de lepidopterología. 2(3). 210–218. 5 indexed citations
5.
Sun, Dantong, Han Zhao, Hai Zhou, et al.. (2023). ARID1A deficiency associated with MMR deficiency and a high abundance of tumor-infiltrating lymphocytes predicts a good prognosis of endometrial carcinoma. Translational Oncology. 33. 101685–101685. 3 indexed citations
6.
Zhou, Haiyu, Dantong Sun, Chunxiao Miao, et al.. (2023). The stage-dependent prognostic role of ARID1A in hepatocellular carcinoma. Translational Cancer Research. 12(11). 3088–3104. 5 indexed citations
7.
Sun, Dantong, Li Wang, Jialin Qu, et al.. (2023). Identification of MET fusions as novel therapeutic targets sensitive to MET inhibitors in lung cancer. Journal of Translational Medicine. 21(1). 150–150. 19 indexed citations
8.
Sun, Dantong, Fei Teng, Tongji Xie, et al.. (2023). Multiomics analysis revealed the mechanisms related to the enhancement of proliferation, metastasis and EGFR-TKI resistance in EGFR-mutant LUAD with ARID1A deficiency. Cell Communication and Signaling. 21(1). 48–48. 12 indexed citations
9.
Sun, Dantong, Wei‐Hua Yan, Jingjuan Zhu, et al.. (2022). Optimal Treatments for NSCLC Patients Harboring Primary or Acquired MET Amplification. Technology in Cancer Research & Treatment. 21. 2213870302–2213870302. 5 indexed citations
10.
Sun, Dantong, et al.. (2022). PD‐L1 blockade by immune checkpoint inhibitors impairs sensitivity to osimertinib in EGFR‐mutant non‐small cell lung cancer cells. SHILAP Revista de lepidopterología. 1(4). 348–349. 3 indexed citations
11.
Hou, Helei, Yongjie Wang, Dantong Sun, et al.. (2022). Neoadjuvant toripalimab plus platinum-paclitaxel chemotherapy in stage II-III non-small cell lung cancer: a single-center, single-arm, phase I study in China. Investigational New Drugs. 41(1). 86–92. 8 indexed citations
12.
Sun, Dantong, Fei Teng, Puyuan Xing, & Junling Li. (2021). ARID1A serves as a receivable biomarker for the resistance to EGFR-TKIs in non-small cell lung cancer. Molecular Medicine. 27(1). 138–138. 14 indexed citations
13.
Sun, Dantong, Yan Zhu, Han Zhao, et al.. (2021). Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis. Cellular Oncology. 44(5). 1019–1034. 33 indexed citations
14.
Sun, Dantong, et al.. (2020). The role of CD28 in the prognosis of young lung adenocarcinoma patients. BMC Cancer. 20(1). 910–910. 9 indexed citations
15.
Sun, Dantong, Wei‐Hua Yan, Hua Zhu, Qiaoling Liu, & Helei Hou. (2020). Case Report: Primary and Acquired Resistance Mechanisms of Nimotuzumab in Advanced Esophageal Squamous Cell Carcinoma Revealed by Targeted Sequencing. Frontiers in Oncology. 10. 574523–574523. 5 indexed citations
16.
Sun, Dantong, Tian Lu, Yan Zhu, et al.. (2020). Subunits of ARID1 serve as novel biomarkers for the sensitivity to immune checkpoint inhibitors and prognosis of advanced non-small cell lung cancer. Molecular Medicine. 26(1). 78–78. 42 indexed citations
17.
Sun, Dantong, Helei Hou, Chuantao Zhang, & Xiaochun Zhang. (2018). The efficacy and safety of apatinib for refractory malignancies: a review and meta-analysis. OncoTargets and Therapy. Volume 11. 6539–6554. 18 indexed citations
18.
Horii, Arata, Jun Kato, Takeshi Nagasaka, et al.. (2012). Development of Invasive Colon Cancer with Microsatellite Instability in a Patient with Hyperplastic Polyposis Syndrome. Japanese Journal of Clinical Oncology. 42(5). 451–454. 3 indexed citations
19.
Liu, Bolin, Dantong Sun, Dihua Yu, Xia Wang, & Mien‐Chie Hung. (1997). Cross-reactivity of C219 Anti-p170mdr-1 Antibody With p185c-erbB2 in Breast Cancer Cells: Cautions on Evaluating p170mdr-1. JNCI Journal of the National Cancer Institute. 89(20). 1524–1529. 38 indexed citations
20.
Sun, Dantong, Siddhartha Kar, & Brian I. Carr. (1995). Differentially expressed genes in TGF-β1 sensitive and resistant human hepatoma cells. Cancer Letters. 89(1). 73–79. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marco Gymnopoulos Breakdown of academic impact, for papers by Denis Tvorogov Breakdown of academic impact, for papers by Ross Lake Breakdown of academic impact, for papers by Verline Justilien Breakdown of academic impact, for papers by Ren Xu Breakdown of academic impact, for papers by Joseph L.‐K. Chan Breakdown of academic impact, for papers by Bárbara Meléndez Breakdown of academic impact, for papers by Laura Gualandi Breakdown of academic impact, for papers by Satoru Osuka Breakdown of academic impact, for papers by Caroline A. Nebhan
Rankless by CCL
2026